Armistice Capital, LLC Neurocrine Biosciences Inc Transaction History

Armistice Capital, LLC

$6.51 Billion
Q3 2025

A detailed history of Armistice Capital, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 697,022 shares of NBIX stock, worth $101 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares

697,022

Previous 676,024 3.11%

Holding current value

$101 Million

Previous $85 Million 15.16%

% of portfolio

1.5%

Previous 1.49%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$123.98 - $146.67 $2.6 Million - $3.08 Million	20,998 Added 3.11%	697,022 $97.8 Million
Q2 2025 Aug 14, 2025	SELL	$87.54 - $128.18 $28.4 Million - $41.6 Million	-324,166 Reduced 32.41%	676,024 $85 Million
Q1 2025 May 15, 2025	BUY	$107.22 - $153.29 $11.6 Million - $16.6 Million	108,190 Added 12.13%	1,000,190 $111 Million
Q4 2024 Feb 14, 2025	BUY	$111.62 - $139.44 $79.3 Million - $99.1 Million	710,619 Added 391.78%	892,000 $122 Million
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $91.3 Million - $122 Million	-797,107 Reduced 81.46%	181,381 $20.9 Million

Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $5.92 Million - $6.48 Million	-45,251 Reduced 4.42%	978,488 $135 Million
Q1 2024 May 15, 2024	SELL	$130.4 - $143.74 $3.16 Million - $3.49 Million	-24,261 Reduced 2.31%	1,023,739 $141 Million
Q4 2023 Feb 13, 2024	SELL	$106.07 - $132.76 $17.9 Million - $22.4 Million	-168,365 Reduced 13.84%	1,048,000 $138 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $40.8 Million - $50.8 Million	-433,635 Reduced 26.28%	1,216,365 $137 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $5.19 Million - $6.08 Million	58,000 Added 3.64%	1,650,000 $156 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $65.1 Million - $85.1 Million	692,000 Added 76.89%	1,592,000 $161 Million
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $45.2 Million - $53.9 Million	-424,000 Reduced 32.02%	900,000 $107 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $51.1 Million - $67.4 Million	674,000 Added 103.69%	1,324,000 $129 Million
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $47.1 Million - $61.6 Million	650,000 New	650,000 $60.9 Million

Others Institutions Holding NBIX

# of Institutions

741

Shares Held

102M

Call Options Held

230K

Put Options Held

477K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account

Armistice Capital, LLC Neurocrine Biosciences Inc Transaction History